Dynamics of cough frequency in adults undergoing treatment for pulmonary tuberculosis

Alvaro Proaño, Marjory A. Bravard, José W. López, Gwenyth O. Lee, David Bui, Sumona Datta, Germán Comina, Mirko Zimic, Jorge Coronel, Luz Caviedes, José L. Cabrera, Antonio Salas, Eduardo Ticona, Nancy M. Vu, Daniela E. Kirwan, Maria Cristina I. Loader, Jon S. Friedland, David A.J. Moore, Carlton A. Evans, Brian H. TraceyRobert H Gilman

Research output: Contribution to journalArticle

Abstract

Background. Cough is the major determinant of tuberculosis transmission. Despite this, there is a paucity of information regarding characteristics of cough frequency throughout the day and in response to tuberculosis therapy. Here we evaluate the circadian cycle of cough, cough frequency risk factors, and the impact of appropriate treatment on cough and bacillary load. Methods. We prospectively evaluated human immunodeficiency virus-negative adults (n = 64) with a new diagnosis of culture- proven, drug-susceptible pulmonary tuberculosis immediately prior to treatment and repeatedly until treatment day 62. At each time point, participant cough was recorded (n = 670) and analyzed using the Cayetano Cough Monitor. Consecutive coughs at least 2 seconds apart were counted as separate cough episodes. Sputum samples (n = 426) were tested with microscopic-observation drug susceptibility broth culture, and in culture-positive samples (n = 252), the time to culture positivity was used to estimate bacillary load. Results. The highest cough frequency occurred from 1 pm to 2 pm, and the lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/ hour, respectively). Cough frequency was higher among participants who had higher sputum bacillary load (P < .01). Pretreatment median cough episodes/hour was 2.3 (interquartile range [IQR], 1.2-4.1), which at 14 treatment days decreased to 0.48 (IQR, 0.0- 1.4) and at the end of the study decreased to 0.18 (IQR, 0.0-0.59) (both reductions P < .001). By 14 treatment days, the probability of culture conversion was 29% (95% confidence interval, 19%-41%). Conclusions. Coughs were most frequent during daytime. Two weeks of appropriate treatment significantly reduced cough frequency and resulted in one-third of participants achieving culture conversion. Thus, treatment by 2 weeks considerably diminishes, but does not eliminate, the potential for airborne tuberculosis transmission.

Original languageEnglish (US)
Pages (from-to)1174-1181
Number of pages8
JournalClinical Infectious Diseases
Volume64
Issue number9
DOIs
StatePublished - 2017

Fingerprint

Pulmonary Tuberculosis
Cough
Tuberculosis
Sputum
Pharmaceutical Preparations

Keywords

  • Airborne transmission
  • Cough
  • Infectiousness
  • Peru
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Dynamics of cough frequency in adults undergoing treatment for pulmonary tuberculosis. / Proaño, Alvaro; Bravard, Marjory A.; López, José W.; Lee, Gwenyth O.; Bui, David; Datta, Sumona; Comina, Germán; Zimic, Mirko; Coronel, Jorge; Caviedes, Luz; Cabrera, José L.; Salas, Antonio; Ticona, Eduardo; Vu, Nancy M.; Kirwan, Daniela E.; Loader, Maria Cristina I.; Friedland, Jon S.; Moore, David A.J.; Evans, Carlton A.; Tracey, Brian H.; Gilman, Robert H.

In: Clinical Infectious Diseases, Vol. 64, No. 9, 2017, p. 1174-1181.

Research output: Contribution to journalArticle

Proaño, A, Bravard, MA, López, JW, Lee, GO, Bui, D, Datta, S, Comina, G, Zimic, M, Coronel, J, Caviedes, L, Cabrera, JL, Salas, A, Ticona, E, Vu, NM, Kirwan, DE, Loader, MCI, Friedland, JS, Moore, DAJ, Evans, CA, Tracey, BH & Gilman, RH 2017, 'Dynamics of cough frequency in adults undergoing treatment for pulmonary tuberculosis', Clinical Infectious Diseases, vol. 64, no. 9, pp. 1174-1181. https://doi.org/10.1093/cid/cix039
Proaño, Alvaro ; Bravard, Marjory A. ; López, José W. ; Lee, Gwenyth O. ; Bui, David ; Datta, Sumona ; Comina, Germán ; Zimic, Mirko ; Coronel, Jorge ; Caviedes, Luz ; Cabrera, José L. ; Salas, Antonio ; Ticona, Eduardo ; Vu, Nancy M. ; Kirwan, Daniela E. ; Loader, Maria Cristina I. ; Friedland, Jon S. ; Moore, David A.J. ; Evans, Carlton A. ; Tracey, Brian H. ; Gilman, Robert H. / Dynamics of cough frequency in adults undergoing treatment for pulmonary tuberculosis. In: Clinical Infectious Diseases. 2017 ; Vol. 64, No. 9. pp. 1174-1181.
@article{5dd87a0561ed446189919d83d7ef4c29,
title = "Dynamics of cough frequency in adults undergoing treatment for pulmonary tuberculosis",
abstract = "Background. Cough is the major determinant of tuberculosis transmission. Despite this, there is a paucity of information regarding characteristics of cough frequency throughout the day and in response to tuberculosis therapy. Here we evaluate the circadian cycle of cough, cough frequency risk factors, and the impact of appropriate treatment on cough and bacillary load. Methods. We prospectively evaluated human immunodeficiency virus-negative adults (n = 64) with a new diagnosis of culture- proven, drug-susceptible pulmonary tuberculosis immediately prior to treatment and repeatedly until treatment day 62. At each time point, participant cough was recorded (n = 670) and analyzed using the Cayetano Cough Monitor. Consecutive coughs at least 2 seconds apart were counted as separate cough episodes. Sputum samples (n = 426) were tested with microscopic-observation drug susceptibility broth culture, and in culture-positive samples (n = 252), the time to culture positivity was used to estimate bacillary load. Results. The highest cough frequency occurred from 1 pm to 2 pm, and the lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/ hour, respectively). Cough frequency was higher among participants who had higher sputum bacillary load (P < .01). Pretreatment median cough episodes/hour was 2.3 (interquartile range [IQR], 1.2-4.1), which at 14 treatment days decreased to 0.48 (IQR, 0.0- 1.4) and at the end of the study decreased to 0.18 (IQR, 0.0-0.59) (both reductions P < .001). By 14 treatment days, the probability of culture conversion was 29{\%} (95{\%} confidence interval, 19{\%}-41{\%}). Conclusions. Coughs were most frequent during daytime. Two weeks of appropriate treatment significantly reduced cough frequency and resulted in one-third of participants achieving culture conversion. Thus, treatment by 2 weeks considerably diminishes, but does not eliminate, the potential for airborne tuberculosis transmission.",
keywords = "Airborne transmission, Cough, Infectiousness, Peru, Tuberculosis",
author = "Alvaro Proa{\~n}o and Bravard, {Marjory A.} and L{\'o}pez, {Jos{\'e} W.} and Lee, {Gwenyth O.} and David Bui and Sumona Datta and Germ{\'a}n Comina and Mirko Zimic and Jorge Coronel and Luz Caviedes and Cabrera, {Jos{\'e} L.} and Antonio Salas and Eduardo Ticona and Vu, {Nancy M.} and Kirwan, {Daniela E.} and Loader, {Maria Cristina I.} and Friedland, {Jon S.} and Moore, {David A.J.} and Evans, {Carlton A.} and Tracey, {Brian H.} and Gilman, {Robert H}",
year = "2017",
doi = "10.1093/cid/cix039",
language = "English (US)",
volume = "64",
pages = "1174--1181",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Dynamics of cough frequency in adults undergoing treatment for pulmonary tuberculosis

AU - Proaño, Alvaro

AU - Bravard, Marjory A.

AU - López, José W.

AU - Lee, Gwenyth O.

AU - Bui, David

AU - Datta, Sumona

AU - Comina, Germán

AU - Zimic, Mirko

AU - Coronel, Jorge

AU - Caviedes, Luz

AU - Cabrera, José L.

AU - Salas, Antonio

AU - Ticona, Eduardo

AU - Vu, Nancy M.

AU - Kirwan, Daniela E.

AU - Loader, Maria Cristina I.

AU - Friedland, Jon S.

AU - Moore, David A.J.

AU - Evans, Carlton A.

AU - Tracey, Brian H.

AU - Gilman, Robert H

PY - 2017

Y1 - 2017

N2 - Background. Cough is the major determinant of tuberculosis transmission. Despite this, there is a paucity of information regarding characteristics of cough frequency throughout the day and in response to tuberculosis therapy. Here we evaluate the circadian cycle of cough, cough frequency risk factors, and the impact of appropriate treatment on cough and bacillary load. Methods. We prospectively evaluated human immunodeficiency virus-negative adults (n = 64) with a new diagnosis of culture- proven, drug-susceptible pulmonary tuberculosis immediately prior to treatment and repeatedly until treatment day 62. At each time point, participant cough was recorded (n = 670) and analyzed using the Cayetano Cough Monitor. Consecutive coughs at least 2 seconds apart were counted as separate cough episodes. Sputum samples (n = 426) were tested with microscopic-observation drug susceptibility broth culture, and in culture-positive samples (n = 252), the time to culture positivity was used to estimate bacillary load. Results. The highest cough frequency occurred from 1 pm to 2 pm, and the lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/ hour, respectively). Cough frequency was higher among participants who had higher sputum bacillary load (P < .01). Pretreatment median cough episodes/hour was 2.3 (interquartile range [IQR], 1.2-4.1), which at 14 treatment days decreased to 0.48 (IQR, 0.0- 1.4) and at the end of the study decreased to 0.18 (IQR, 0.0-0.59) (both reductions P < .001). By 14 treatment days, the probability of culture conversion was 29% (95% confidence interval, 19%-41%). Conclusions. Coughs were most frequent during daytime. Two weeks of appropriate treatment significantly reduced cough frequency and resulted in one-third of participants achieving culture conversion. Thus, treatment by 2 weeks considerably diminishes, but does not eliminate, the potential for airborne tuberculosis transmission.

AB - Background. Cough is the major determinant of tuberculosis transmission. Despite this, there is a paucity of information regarding characteristics of cough frequency throughout the day and in response to tuberculosis therapy. Here we evaluate the circadian cycle of cough, cough frequency risk factors, and the impact of appropriate treatment on cough and bacillary load. Methods. We prospectively evaluated human immunodeficiency virus-negative adults (n = 64) with a new diagnosis of culture- proven, drug-susceptible pulmonary tuberculosis immediately prior to treatment and repeatedly until treatment day 62. At each time point, participant cough was recorded (n = 670) and analyzed using the Cayetano Cough Monitor. Consecutive coughs at least 2 seconds apart were counted as separate cough episodes. Sputum samples (n = 426) were tested with microscopic-observation drug susceptibility broth culture, and in culture-positive samples (n = 252), the time to culture positivity was used to estimate bacillary load. Results. The highest cough frequency occurred from 1 pm to 2 pm, and the lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/ hour, respectively). Cough frequency was higher among participants who had higher sputum bacillary load (P < .01). Pretreatment median cough episodes/hour was 2.3 (interquartile range [IQR], 1.2-4.1), which at 14 treatment days decreased to 0.48 (IQR, 0.0- 1.4) and at the end of the study decreased to 0.18 (IQR, 0.0-0.59) (both reductions P < .001). By 14 treatment days, the probability of culture conversion was 29% (95% confidence interval, 19%-41%). Conclusions. Coughs were most frequent during daytime. Two weeks of appropriate treatment significantly reduced cough frequency and resulted in one-third of participants achieving culture conversion. Thus, treatment by 2 weeks considerably diminishes, but does not eliminate, the potential for airborne tuberculosis transmission.

KW - Airborne transmission

KW - Cough

KW - Infectiousness

KW - Peru

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85020044072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020044072&partnerID=8YFLogxK

U2 - 10.1093/cid/cix039

DO - 10.1093/cid/cix039

M3 - Article

C2 - 28329268

AN - SCOPUS:85020044072

VL - 64

SP - 1174

EP - 1181

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 9

ER -